These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12478328)

  • 1. Ciclopiroxolamine cream for treating seborrheic dermatitis: a double-blind parallel group comparison.
    Unholzer A; Varigos G; Nicholls D; Schinzel S; Nietsch KH; Ulbricht H; Korting HC
    Infection; 2002 Dec; 30(6):373-6. PubMed ID: 12478328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage.
    Abeck D;
    Int J Dermatol; 2004 Jul; 43 Suppl 1():13-6. PubMed ID: 15271195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
    Elewski B
    Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial.
    Altmeyer P; Hoffmann K;
    Int J Dermatol; 2004 Jul; 43 Suppl 1():9-12. PubMed ID: 15271194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
    Seckin D; Gurbuz O; Akin O
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo.
    Shuster S; Meynadier J; Kerl H; Nolting S
    Arch Dermatol; 2005 Jan; 141(1):47-52. PubMed ID: 15655141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial.
    Lebwohl M; Plott T
    Int J Dermatol; 2004 Jul; 43 Suppl 1():17-20. PubMed ID: 15271196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
    Elewski BE; Abramovits W; Kempers S; Schlessinger J; Rosen T; Gupta AK; Abraham S; Rowell R
    J Drugs Dermatol; 2007 Oct; 6(10):1001-8. PubMed ID: 17966177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of a new ciclopiroxolamine/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment.
    Lorette G; Ermosilla V
    Eur J Dermatol; 2006; 16(5):558-64. PubMed ID: 17101479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study.
    Diehl C; Ferrari A
    J Drugs Dermatol; 2013 Mar; 12(3):312-5. PubMed ID: 23545914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%.
    Clin Ther; 1985; 7(5):574-83. PubMed ID: 2865009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis.
    Chosidow O; Maurette C; Dupuy P
    Dermatology; 2003; 206(3):233-40. PubMed ID: 12673081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of head and neck dermatitis with ciclopiroxolamine cream--results of a double-blind, placebo-controlled study.
    Mayser P; Kupfer J; Nemetz D; Schäfer U; Nilles M; Hort W; Gieler U
    Skin Pharmacol Physiol; 2006; 19(3):153-8. PubMed ID: 16612143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study comparing the efficacy and tolerance of a lipohydroxy acid shampoo to a ciclopiroxolamine shampoo in the treatment of scalp seborrheic dermatitis.
    Seite S; Rougier A; Talarico S
    J Cosmet Dermatol; 2009 Dec; 8(4):249-53. PubMed ID: 19958427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial.
    Elewski B; Ling MR; Phillips TJ
    J Drugs Dermatol; 2006; 5(7):646-50. PubMed ID: 16865870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciclopirox gel for seborrheic dermatitis of the scalp.
    Aly R; Katz HI; Kempers SE; Lookingbill DP; Lowe N; Menter A; Morman M; Savin RC; Wortzman M
    Int J Dermatol; 2003 Sep; 42 Suppl 1():19-22. PubMed ID: 12895183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis.
    Dupuy P; Maurette C; Amoric JC; Chosidow O;
    Br J Dermatol; 2001 May; 144(5):1033-7. PubMed ID: 11359393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis.
    Wannanukul S; Chiabunkana J
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S68-71. PubMed ID: 16083165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.